| Formulary Chapter 13: Skin - Full Chapter
|
| 13.11 |
Skin cleansers, antiseptics, and desloughing agents |
|
|
Alcohol hand rub gel
|
Formulary
|
|
|
|
Alcohol impregnated wipes
((Clini-wipes, Alcowipes))
|
Formulary
|
contains 70% isopropyl alcohol or methylated spirit
|
|
|
Industrial Methylated Spirit BP
|
Formulary
|
70% liquid
|
|
|
Skin preparation swabs Sterets
|
Formulary
|
containing 70% isopropyl alcohol
|
|
|
Sodium Chloride
|
Formulary
|
Sterile solution - bottles 25ml & 100ml sachets (Normosol) & 45ml plastic ampoules/pods (Miniversol)
|
|
|
Water for irrigation
|
Formulary
|
|
|
|
| 13.11.01 |
Alcohols and saline |
|
|
| 13.11.02 |
Chlorhexidine salts |
|
|
Chlorhexidine Acetate 1% Dusting Powder
|
Formulary
|
|
|
|
Chlorhexidine Gluconate
|
Formulary
|
0.02% & 0.05% solutions, 25ml & 100ml sachets
0.5% solution in 70% methylated spirit (pink, colourless & red staining)
2.5% in 70% methylated spirit wipes
0.5% hand rub (contains 70% isopropyl alcohol + emollients)
4% surgical scrub
2% in 70% isopropyl alcohol wipes (Sanicloth & Clinell)
skin swabs & skin cleanser
3ml & 10.5ml applicators (Chloraprep)
1% Obstetric cream
4% scrub 100ml and 500ml (used as a soap substitute in patients with hidradenitis under special advice)
|
|
|
Prontosan
(To be prescribed/ used only on the advice of tissue viability specialists)
|
Formulary
|
solution containing Betadine 0.1% (surfactant) and Polyhexadine 0.1% (a chlorhexadine polymer). Mainly for use from 40ml plastic ampoules. Also available as gel.
|
|
|
| 13.11.03 |
Cationic surfactants and soaps |
|
|
| 13.11.04 |
Iodine and Chlorine |
|
|
Povidone-Iodine
|
Formulary
|
2.5% dry powder spray
10% alcoholic solution
7.5% surgical scrub
10% antiseptic solution (aqueous)
|
|
|
Sodium dichloroisocyanurate
|
Formulary
|
500mg & 5g solution tablets: Granules.
|
|
|
Sodium Hypochorite 1% sterilising Solution 1%
|
 Unlicensed
|
|
|
|
| 13.11.05 |
Phenolics |
|
|
Triclosan (Manusept®)
|
Formulary
|
|
|
|
Triclosan 1% (Skinsan®)
|
Formulary
|
|
|
|
Triclosan 2% (Aquasept®)
|
Formulary
|
|
|
|
| 13.11.06 |
Oxidisers, and dyes |
|
|
Potassium Permanganate Solution
|
First Choice
|
Solution Tablets - 400mg
|
|
|
Hydrogen Peroxide 1% cream (Crystacide®)
|
Formulary
|
|
|
|
Silver Nitrate Pencil
(used on advice from dermatologists)
|
Formulary
|
40%, 75% and 95%
|
|
|
Bonney’s Blue
(for limited use in some operating theatres only)
|
Unlicensed
|
Paint containing brilliant green and crystal violet
|
|
|
Crystal Violet
(for limited use in some operating theatres / critical care areas only)
|
Unlicensed
|
0.5% paint
|
|
|
Magenta paint BPC (Castellani’s paint)
|
Unlicensed
|
Paint containg magenta 0.4% boric acid 0.8% phenol 0.0004%, resorcinol 8%, acetone and alcohol (or industrial methylated spirit)
|
|
|
| 13.11.07 |
Desloughing agents |
|
|
‘Free Range’ Larvae
(Sterile larvae (maggots) used for the management of sloughy wounds.)
|
Formulary
|
|
|
|
BioFOAM dressing
(maggots that are enclosed in net pouches)
|
Formulary
|
|
|
|
| 13.11.07 |
Desloughing agents |
|
|
| 13.11.07 |
Growth factor |
|
|
| .... |
| Non Formulary Items |
Bacaplermin (Regranex®)
|
Non Formulary
|
|
|
|
Becaplermin
|
Non Formulary
|
|
|
|
Cetrimide
|
Non Formulary
|
|
|
|
Chlorhexidine (Cepton®)
|
Non Formulary
|
|
|
|
Chlorhexidine (Hibi®)
|
Non Formulary
|
|
|
|
Chlorhexidine 0.015% with Cetrimide 0.15% (Tisept®)
|
Non Formulary
|
|
|
|
Chlorhexidine 0.05% (Unisept®)
|
Non Formulary
|
|
|
|
Chlorhexidine 0.5% (Aqueous)
|
Non Formulary
|
|
|
|
Chlorhexidine 2% in Isopropyl Alcohol 70% (ChloraPrep®)
|
Non Formulary
|
|
|
|
Chlorhexidine 4%
|
Non Formulary
|
|
|
|
Chlorhexidine Concentrates (Hibitane 5% Concentrate®)
|
Non Formulary
|
|
|
|
Chlorhexidine Concentrates with cetrimide (Hibicet Hospital Concentrate®)
|
Non Formulary
|
|
|
|
Chlorhexidine Solution 2.5% (≡ Chlorhexidine 0.5%) (Alcoholic)
|
Non Formulary
|
|
|
|
Chlorhexidine with cetrimide (Travasept®)
|
Non Formulary
|
|
|
|
Hibitane Obstetric®
|
Non Formulary
|
|
|
|
Hydrogen Peroxide Solution BP
|
Non Formulary
|
|
|
|
Potassium Permanganate (Permitabs®)
|
Non Formulary
|
|
|
|
Povidone-Iodine (Savlon® Dry Antiseptic)
|
Non Formulary
|
|
|
|
Sodium Chloride (Flowfuser®)
|
Non Formulary
|
|
|
|
Sodium Chloride (Irriclens®)
|
Non Formulary
|
|
|
|
Sodium Chloride (Miniversol®)
|
Non Formulary
|
|
|
|
Sodium Chloride (Stericlens®)
|
Non Formulary
|
|
|
|
Sodium Chloride (Steripod®)
|
Non Formulary
|
|
|
|
Sodium Chloride 0.9%
|
Non Formulary
|
|
|
|
Sterile Larvae (Maggots) (LarvE®)
|
Non Formulary
|
|
|
|
Triclosan 2% (Ster-Zac Bath Concentrate®)
|
Non Formulary
|
|
|
|
| |
Key |
|
|
|
|
Cytotoxic Drug
|
|
|
Controlled Drug
|
|
High Cost Medicine
|
|
Cancer Drugs Fund
|
|
NHS England |
|
Homecare |
|
CCG |
|
Traffic Light Status Information
| Status |
Description |
|
Drugs for hospital use or use by a specialist within specialist centre only. Initiation and monitoring of treatment should remain under the total responsibility of the appropriate hospital clinician or specialist.
These drugs should only be prescribed under the direct supervision of that clinician or specialist and are not suitable for shared care arrangements. The drug should be supplied via the hospital or specialist centre for the duration of treatment.
|
|
These are specialist drugs which must be initiated by secondary care specialist prescribers, but with the potential to transfer prescribing to primary care within written and agreed shared care protocols and according to the agreed process for transfer of care.
For these drugs, in order to ensure patient safety, some aspects of care must remain with the specialist due to their complexity e.g. monitoring of disease or drug response. Other more routine aspects can be transferred to the GP e.g. monitoring of adverse effects and supply of the medicine. The specific responsibilities of the specialist and GP are defined in the shared care agreement for each drug.
Shared care agreements are still under development for some amber drugs. Until these are available, it would be expected that any shared care request from secondary care to a GP would be accompanied by written information which defines prescribing and monitoring responsibilities. The hospital specialist should also provide the GP with enough information and support to allow the safe transfer and ongoing management of prescribing into primary care.
|
|
Drugs which should usually be initiated in secondary care, or by a specialist clinician, but can be safely maintained in primary care with very little or no monitoring required. In some cases there may be a further restriction for use outlined - these will be defined in each case. |
|
These are defined as new and established drugs, which may be prescribed, initiated, changed or maintained on FP10 by the GP and, if appropriate, discontinued without recourse to secondary care.
N.B. DRUGS NOT IDENTIFIED IN THE FORMULARY BY A RED, AMBER OR GREEN+ SYMBOL ARE CLASSIFIED AS GREEN. |
|
|
|
